ArticleBladder cancer (Amsterdam, Netherlands)2018

Double-Blind, Randomized, Placebo-controlled Studies Evaluating Apaziquone (E09, Qapzola™) Intravesical Instillation Post Transurethral Resection of Bladder Tumors for the Treatment of Low-risk Non-Muscle Invasive Bladder Cancer.

Lawrence Karsh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.